Aim and Scope

"Iranian Journal of Cancer Prevention" is a quarterly peer-reviewed publication of the Cancer Research Centre (CRC), Shahid Beheshti University of Medical Sciences (SBUMS), Tehran, I.R of Iran.
Predictive oncology follows a holistic approach in cancer prevention by risk factor management, considering social determinants of health, biological evaluation, assessing carcinogenesis and predisposing factors, early detection and diagnosing precancerous lesions, prognostic evaluation of malignant tumour transformation and progression, control of genotoxic exposures, lifestyle modification, cancer management (surgery, chemoradiotherapy, immuno-hormone therapy, psychological and spiritual care, etc), surviving patients with the highest possible quality of life, rehabilitation and palliative care.
"Iranian Journal of Cancer Prevention" appreciates articles in all aspects of cancer including:
• Risk factor management: Life style, gene–environment interactions, molecular triggers and strategies for reducing risk.
• Public health issues: Epidemiology, cost-effectiveness of procedures, health technology assessment, cancer registry, social determinants of health, health needs and impact assessment, quality of life measurement, public and professional education, and cancer control programmes.
• Cancer diagnosis and prognosis: Molecular markers; diagnostic imaging; defining tumour margins; detecting minimal residual disease.
• New approaches to cancer therapy: Surgery, radiation therapy, rational drug design, gene therapy, immunotherapy, combination therapies, combating drug resistance, targeting therapies to the individual and complementary medicine, spiritual and psychological in particular.
• Experimental systems and techniques: Cell culture and animal models, genomic and proteomic approaches to studying cancer.
• Cancer-associated conditions: Cancer pain, cachexia, symptoms associated with treatment (hair loss, anaemia, gastrointestinal disorders), psychosocial aspects of cancer.
• Ethical and legal issues surrounding cancer research: Trial design, genetic screening, communicating with patients and families, death issues, research policy and advocacy.
"Iranian Journal of Cancer Prevention" focuses on advances in epidemiology, genetics, translational therapeutics, molecular medicine, pathology, new approaches in surgery and radiation therapy, and biotechnologies that have an impact on clinical oncology modalities. All of these goals depend on a combination of basic, applied, and health system research.
The Peer Review System: Submitted Manuscripts will be reviewed by the editorial board and will be accepted if they meet the "Iranian Journal of Cancer Prevention" criteria and stand in harmony with the standards of the journal. Reviewers deal with manuscripts blindly and discuss the comments in editorial sessions. Reviews are then sent to the corresponding authors for suggested modifications and the corrected version of the manuscript will be peer-reviewed for a second time by two or three external reviewers.